Bupropion HCL ER
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-23-D-0002
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued an award notice for the national contract SPE2D2-23-D-0002 pertaining to Bupropion HCL ER, a pharmaceutical product. The contract is classified under NAICS code 325412, which covers Pharmaceutical Preparation Manufacturing, and product service code 6505, indicating drugs and biologicals. The place of performance for this contract is Hauppauge, New York, United States.
This contract is structured as a multi-year national agreement for the supply of Bupropion HCL ER, with several modifications reflecting the invocation of option years and the incorporation of regulatory clauses. Specifically, modifications P00006, P00008, and P00010 have been issued to activate option years two, three, and four, respectively, ensuring continued supply and contract performance over an extended period. These modifications demonstrate the government’s commitment to maintaining a stable and reliable procurement channel for this essential pharmaceutical product.
Additional modifications have been made to address compliance and regulatory requirements. Modification P00005 incorporates FAR 52.204-30, which relates to the Federal Acquisition Supply Chain Security Act Orders, underscoring the importance of supply chain integrity and security in federal procurement. Modification P00009 introduces clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1), effective April 2026, reflecting the agency’s focus on diversity, equity, and inclusion in contractor practices. Modification P00007 implements DoD Class Deviations 2025-O0003 and 2025-O0004, further aligning the contract with current Department of Defense procurement policies.
The contract is managed by DLA Troop Support, a federal office within the Defense Logistics Agency, with primary and secondary points of contact provided for contractor inquiries: Kyle Lewicki ([email protected], 445-737-0977) and Jason Wray ([email protected], 445-737-6304). The notice remains active as of September 14, 2026, and is accessible via SAM.gov (Opportunity ID: 885609e0a0a44507927f0fb893d641d5).
Contractors considering this opportunity should note the long-term nature of the agreement, the requirement for compliance with federal supply chain and DEI regulations, and the expectation for consistent delivery of Bupropion HCL ER to the specified location in Hauppauge, NY. The contract’s scope and requirements are likely to remain stable throughout its lifecycle, focusing on the reliable manufacturing and supply of pharmaceutical preparations in accordance with federal standards and evolving regulatory mandates.
Documents11